In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR

Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection

(2021) Byoung Kwon Park et al.   Biomolecules & Therapeutics

TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2

(2021) Dhriti Kaushik et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The challenge of emerging SARS-CoV-2 mutants to vaccine development

(2021) Rong Li et al.   Journal of Genetics and Genomics

SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human Microglia

(2021) Ritu Mishra et al.   Frontiers in Immunology

miRNAs; a novel strategy for the treatment of COVID‐19

(2021) Hao Ying et al.   CELL BIOLOGY INTERNATIONAL

In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3′-UTR

(2021) María Asunción Barreda-Manso et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells

(2021) Fei Meng et al.   Cells

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A novel coronavirus outbreak of global health concern

(2020) Chen Wang et al.   LANCET

High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p

(2020) Jessica Gasparello et al.   Nucleic Acid Therapeutics

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

(2020) Mehmet Soy et al.   CLINICAL RHEUMATOLOGY

COVID-19 cytokine storm: The anger of inflammation

(2020) Mehdi Mahmudpour et al.   CYTOKINE

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome

(2020) Toshio Hirano et al.   IMMUNITY

MicroRNA‑93 contributes to the suppression of lung inflammatory responses in LPS‑induced acute lung injury in mice via the TLR4/MyD88/NF‑κB signaling pathway

(2020) Hu Gao et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Clinical and immunological features of severe and moderate coronavirus disease 2019

(2020) Guang Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

COVID‐19 diagnosis and management: a comprehensive review

(2020) Giuseppe Pascarella et al.   JOURNAL OF INTERNAL MEDICINE

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

Translating IL-6 biology into effective treatments

(2020) Ernest H. Choy et al.   Nature Reviews Rheumatology

Cytokine storm in COVID ‐19 and parthenolide: preclinical evidence

(2020) Mohsen Bahrami et al.   PHYTOTHERAPY RESEARCH

Characterization of the Inflammatory Response to Severe COVID-19 Illness

(2020) Oliver J McElvaney et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks

(2020) Salvatore Crisafulli et al.   BIODRUGS

Statins: Could an old friend help in the fight against COVID‐19?

(2020) Raul R. Rodrigues‐Diez et al.   BRITISH JOURNAL OF PHARMACOLOGY

Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China

(2020) Ying Chi et al.   JOURNAL OF INFECTIOUS DISEASES

Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway

(2020) Qinhai Ma et al.   PHARMACOLOGICAL RESEARCH

Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases

(2020) Dorothy H.J. Cheong et al.   PHARMACOLOGICAL RESEARCH

Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19)

(2020) Yu-Feng Huang et al.   PHARMACOLOGICAL RESEARCH

COVID-19 Vaccine: A comprehensive status report

(2020) Simran Preet Kaur et al.   VIRUS RESEARCH

Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients

(2020) Joaquim Bosch-Barrera et al.   Journal of Clinical Medicine

Cytokine prediction of mortality in COVID19 patients

(2020) Mathilda Mandel et al.   CYTOKINE

COVID-19: fighting the invisible enemy with microRNAs

(2020) Neeraj Chauhan et al.   Expert Review of Anti-Infective Therapy

Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2

(2020) Xiaolei Li et al.   IMMUNOLOGIC RESEARCH

A new approach for COVID-19 treatment by micro-RNA

(2020) Sobhy Hassab El-Nabi et al.   MEDICAL HYPOTHESES

Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation

(2020) Isabelle Amigues et al.   Expert Review of Clinical Immunology

Clinical manifestation and disease progression in COVID-19 infection

(2020) Ping-Hsing Tsai et al.   Journal of the Chinese Medical Association

Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure

(2020) Christopher S. King et al.   PLoS One

Lung transplantation for patients with severe COVID-19

(2020) Ankit Bharat et al.   Science Translational Medicine

Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome

(2020) Laura Pandolfi et al.   BMC Pulmonary Medicine

Biomimetic Nanoparticles Potentiate the Anti-Inflammatory Properties of Dexamethasone and Reduce the Cytokine Storm Syndrome: An Additional Weapon against COVID-19?

(2020) Roberto Molinaro et al.   Nanomaterials

NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients

(2020) Ralf Kircheis et al.   Frontiers in Immunology

Circular RNA 0039411 is involved in neodymium oxide-induced inflammation and anti-proliferation in a human bronchial epithelial cell line via sponging miR-93-5p

(2019) Qiuhan Hua et al.   TOXICOLOGICAL SCIENCES

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors

(2019) Marijo Bilusic et al.   Journal for ImmunoTherapy of Cancer

The role of cigarette smoke-induced epigenetic alterations in inflammation

(2019) Dandan Zong et al.   Epigenetics & Chromatin

Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle

(2019) Jessica Gasparello et al.   Molecular Therapy-Nucleic Acids

Small RNA and transcriptome sequencing reveal the role of miR-199a-3p in inflammatory processes in cystic fibrosis airways

(2018) Pauline Bardin et al.   JOURNAL OF PATHOLOGY

MicroRNAs and Osteoarthritis

(2018) Charles Malemud   Cells

BCL11A mRNA Targeting by miR-210: A Possible Network Regulating γ-Globin Gene Expression

(2017) Jessica Gasparello et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Regulation of IL-8 gene expression in gliomas by microRNA miR-93

(2015) Enrica Fabbri et al.   BMC CANCER

miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production

(2015) Irene K. Oglesby et al.   EUROPEAN RESPIRATORY JOURNAL

High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222

(2015) ELEONORA BROGNARA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Expression of microRNA-93 and Interleukin-8 duringPseudomonas aeruginosa–Mediated Induction of Proinflammatory Responses

(2014) Enrica Fabbri et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells

(2014) F. Cervellati et al.   TOXICOLOGY IN VITRO

Mapping the Transcriptional Machinery of the IL-8 Gene in Human Bronchial Epithelial Cells

(2011) V. Bezzerri et al.   JOURNAL OF IMMUNOLOGY